Michelle L. Rockey, PharmD, BCOP FHOPA, is the Oncology Clinical Coordinator for The University of Kansas Health System. Dr. Rockey is also the PGY2 Oncology Pharmacy Residency Director and is an Adjunct Assistant Clinical Professor for the University of Kansas School of Pharmacy. Dr. Rockey received her PharmD from The University of Kansas. She completed both her Pharmacy Practice Residency and Oncology Pharmacy Residency at the University Hospital in Cincinnati, Ohio and has been a Board Certified Oncology Pharmacist since 2005. Dr. Rockey has practiced in several different oncology practice settings in multiple states and has been a PGY2 Oncology Program Director for two different program for over 25 Oncology Residents. She has been an active HOPA member since 2005 serving on multiple committees and taskforces as well as on the HOPA board. Additional recent professional activities include serving on the ASHP Oncology Residency Standards Revision Workgroup, Faculty and Planning member for the ASCO Advance Practice Provider Certificate Program, and Adjunct Assistant Professor at The James L. Winkle College of Pharmacy at the University of Cincinnati in Cincinnati, Ohio.